Clinical Trial Update: Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

A Phase 3 pediatric trial assessing the safety and efficacy of Asacol (mesalamine) given every 12 hours in children and adolescents with active ulcerative colit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Asacol (mesalamine)

Snippet

Sponsor: Warner Chilcott | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2012-04-04